CMP 3.03% 32.0¢ compumedics limited

Ann: MEG FDA Approval, page-3

  1. 184 Posts.
    lightbulb Created with Sketch. 56
    Fantastic news......

    Highlights: • Compumedics’ Neuroscan Orion LifeSpan™ MEG receives US Food and Drug Administration (FDA) approval in the United States, following installation at Barrow Neurological Institute in Arizona, USA

    • Sites can now use the MEG for routine clinical examinations and bill for insurance reimbursement

    • Significant milestone for the company’s MEG sales and marketing efforts

    • Company continues to actively pursue forty identified MEG opportunities around the world, with four opportunities substantively advanced
 
watchlist Created with Sketch. Add CMP (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
-0.010(3.03%)
Mkt cap ! $56.69M
Open High Low Value Volume
33.0¢ 34.0¢ 31.5¢ $28.12K 87.30K

Buyers (Bids)

No. Vol. Price($)
1 11098 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 8695 1
View Market Depth
Last trade - 14.53pm 19/06/2024 (20 minute delay) ?
CMP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.